BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3835339)

  • 1. [Electron microscopic observation of the renal tubular damage after administration of cis-diamminedichloroplatinum (II)].
    Kimura S; Nakazono M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1985 Oct; 76(10):1439-53. PubMed ID: 3835339
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental ultrastructural and X-ray microanalysis study of cisplatin in the rat: intracellular localization of platinum.
    Berry JP; Brille P; LeRoy AF; Gouveia Y; Ribaud P; Galle P; Mathé G
    Cancer Treat Rep; 1982 Jul; 66(7):1529-33. PubMed ID: 7201344
    [No Abstract]   [Full Text] [Related]  

  • 4. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats.
    Nosaka K; Nakada J; Endou H
    Kidney Int; 1992 Jan; 41(1):73-9. PubMed ID: 1593864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyst formation in rat kidney induced by cis-platinum administration.
    Dobyan DC; Hill D; Lewis T; Bulger RE
    Lab Invest; 1981 Sep; 45(3):260-8. PubMed ID: 7196972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations.
    Jones TW; Chopra S; Kaufman JS; Flamenbaum W; Trump BF
    Lab Invest; 1985 Apr; 52(4):363-74. PubMed ID: 4039014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosfomycin protects against tubulotoxicity induced by cis-diaminedichloroplatin and cyclosporin A in the rat.
    Sack K; Schulz E; Marre R; Kreft B
    Klin Wochenschr; 1987 Jun; 65(11):525-7. PubMed ID: 3613466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of protective effect of solcoseryl on cisplatin nephrotoxicity].
    Satoh H; Mori Y
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):89-93. PubMed ID: 1729962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced tubular injury studied by water-soluble synthetic polymers.
    Rypácek F; Cífková I; Drobník J
    Physiol Bohemoslov; 1984; 33(6):481-8. PubMed ID: 6241721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure following intraperitoneal injection of cis-diamminedichloroplatinum.
    Hosokawa S; Kohira S; Tomotoshi T
    Urol Int; 1984; 39(4):246-9. PubMed ID: 6541388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat: enzyme histochemical studies.
    Jones TW; Chorpa S; Kaufman JS; Flamenbaum W; Trump BF
    Toxicol Pathol; 1985; 13(4):296-305. PubMed ID: 2871624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of β-catenin in regenerating renal tubules of cisplatin-induced kidney failure in rats.
    Terada N; Karim MR; Izawa T; Kuwamura M; Yamate J
    Clin Exp Nephrol; 2018 Dec; 22(6):1240-1250. PubMed ID: 29802483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and tridimensional studies of tubular cystic degeneration in rat kidney following exposure to cisplatin.
    Zanen J; Carinci V; Nonclercq D; Toubeau G; Laurent G; Heuson-Stiennon JA
    Anal Cell Pathol; 1993 Nov; 5(6):353-66. PubMed ID: 8305331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE; Walser MM; Quebbemann AJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different radioactive renal agents in cisplatin-induced tubular toxicity in rats.
    McAfee JG; Subramanian G; Thomas FD; Hellwig B; Roskopf M
    J Nucl Med; 1989 May; 30(5):659-65. PubMed ID: 2715830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues.
    Sugihara K; Nakano S; Koda M; Tanaka K; Fukuishi N; Gemba M
    Jpn J Pharmacol; 1987 Mar; 43(3):247-52. PubMed ID: 3586414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis.
    Shiraishi F; Curtis LM; Truong L; Poss K; Visner GA; Madsen K; Nick HS; Agarwal A
    Am J Physiol Renal Physiol; 2000 May; 278(5):F726-36. PubMed ID: 10807584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute structural changes in renal tubular epithelium following administration of nitrilotriacetate.
    Merski JA
    Food Cosmet Toxicol; 1981 Aug; 19(4):463-70. PubMed ID: 7274880
    [No Abstract]   [Full Text] [Related]  

  • 20. Lovastatin prevents cisplatin-induced activation of pro-apoptotic DNA damage response (DDR) of renal tubular epithelial cells.
    Krüger K; Ziegler V; Hartmann C; Henninger C; Thomale J; Schupp N; Fritz G
    Toxicol Appl Pharmacol; 2016 Feb; 292():103-14. PubMed ID: 26739623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.